Trailing-twelve-month (TTM) revenue is $102.31 Million with a year-over-year growth of +59.53%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $26,030,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-12 |
| Q4 FY2025Period ended 2025-12-31 | $32,861,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-24 |
| Q1 FY2026Period ended 2026-03-31 | $17,265,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-05 |
| Q2 FY2026Period ended 2026-06-30 | $26,157,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $102,313,000 |
Current P/S: $31,290,350 market capitalization ÷ $102,313,000 TTM revenue = 0.31x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T15:00:30.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $26.16M.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 22 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:02:41.153Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|
| Product | $227M | $64M | $102M | $38M | $80M |
| Service | $43M | $59M | $25M | $10M | $19M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|
| All Other | $227,000 | $20,000 | $733,000 | N/A |
| AUSTRALIA | $25M | $7M | $4M | $1M |
| UNITED STATES | $98M | $120M | $42M | $98M |
$102.31M
$102.31 Million
+59.53%
vs. $64.13M a year ago (TTM)
(14.17%)
5 Year compound annual growth rate
1 Year
+59.53%
3 Year
(4.11%)
5 Year
(14.17%)
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $99.69M | +$52.33M | +110.51% |
| 2024 | $47.35M | ($79.65M) | (62.71%) |
| 2023 | $127.00M | +$3.94M | +3.20% |
| 2022 | $123.07M | ($147.46M) | (54.51%) |
| 2021 | $270.52M | +$83.17M | +44.39% |
| 2020 |
TTM Growth
+59.53%
3-Year CAGR
(4.11%)
5-Year CAGR
(14.17%)
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T15:02:41.153Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $187.35M |
| +$134.23M |
| +252.67% |
